Veterinary Medicines

Genestran 75 micrograms/ml solution for injection for cattle, horses and pigs

Authorised
  • R-Cloprostenol sodium
Download as PDF

Product identification

Medicine name:
Genestran 75 micrograms/ml solution for injection for cattle, horses and pigs
Genestran Vet 75 mikrogram/ml injeksjonsvæske, oppløsning, for storfe, hest og svin
Active substance:
  • R-Cloprostenol sodium
Target species:
  • Cattle
  • Horse
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • R-Cloprostenol sodium
    78.88
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        1
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        1
        day
      • Milk
        0
        hour
    • Pig
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG02AD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Available in:
  • Norway
Package description:
  • Colourless vial of type I glass containing 20 ml of solution for injection, with chlorobutyl rubber stopper and aluminium cap.Presentation: Cardboard box of 1 vial of 20 ml
  • Colourless vial of type I glass containing 50 ml of solution for injection, with chlorobutyl rubber stopper and aluminium cap.Presentation: Cardboard box of 1 vial of 50 ml
  • Colourless vial of type I glass containing 20 ml of solution for injection, with chlorobutyl rubber stopper and aluminium cap.Presentation: Cardboard box of 5 vials of 20 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
  • Industrial Veterinaria S.A.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 08-6050
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0228/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Estonia
  • France
  • Germany
  • Iceland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 25/09/2024
Download
Norwegian (PDF)
Published on: 9/10/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 9/10/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."